Vasculitis Treatment
血管炎治疗
Duration
6-12 months induction and maintenance
Recovery
3-6 months for remission induction
Savings
~74% vs US
Average savings compared to US prices
Specialized vasculitis treatment covering ANCA-associated vasculitis, Takayasu arteritis, and Behcet's disease using rituximab, cyclophosphamide, and novel targeted agents. Chinese hospitals have particular expertise in Takayasu arteritis and Behcet's disease, which are more prevalent in East Asian populations. Advanced vascular imaging and biopsy capabilities ensure accurate diagnosis and monitoring.
Vasculitis Classification
ANCA testing, tissue biopsy, CTA/MRA vascular imaging, and organ damage assessment
Duration: 3-5 daysRemission Induction
High-dose corticosteroids with cyclophosphamide or rituximab depending on vasculitis type and severity
Duration: 3-6 monthsMaintenance Therapy
Transition to azathioprine, mycophenolate, or rituximab maintenance with steroid tapering
Duration: 12-24 monthsVascular Monitoring
Regular imaging surveillance, inflammatory marker tracking, and organ function monitoring
Duration: Ongoing- Expertise in Asian-prevalent vasculitis types (Takayasu, Behcet's)
- Advanced vascular imaging at lower cost
- Access to rituximab and novel complement inhibitors
- Comprehensive multiorgan monitoring protocols
- Severe infection risk during induction therapy
- Organ damage from undertreated disease
- Cyclophosphamide risks including bladder toxicity and infertility
- Relapse risk after treatment discontinuation
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.